187 related articles for article (PubMed ID: 1650650)
41. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
Jiang MJ; Chan CF; Chang YL
Life Sci; 1994; 54(25):2005-13. PubMed ID: 7515455
[TBL] [Abstract][Full Text] [Related]
42. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
43. Differential effect of halothane and forskolin on platelet cytosolic Ca2+ mobilization and aggregation.
Corbin F; Blaise G; Sauvé R
Anesthesiology; 1998 Aug; 89(2):401-10. PubMed ID: 9710399
[TBL] [Abstract][Full Text] [Related]
44. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
45. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
Kawasaki J; Kobayashi S; Miyagi Y; Nishimura J; Fujishima M; Kanaide H
Br J Pharmacol; 1997 Jul; 121(5):977-85. PubMed ID: 9222556
[TBL] [Abstract][Full Text] [Related]
46. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
Lippton HL; Horwitz PM; McNamara DB; Landry AZ; Kadowitz PJ
Prostaglandins Leukot Med; 1984 Oct; 16(1):121-30. PubMed ID: 6440150
[TBL] [Abstract][Full Text] [Related]
47. Protein kinase C plays a key role in the cross-talk between intracellular signalings via prostanoid receptors in a megakaryoblastic cell line, MEG-01s.
Watanabe T; Sunaga S; Togo M; Satoh H; Higashihara M; Hashimoto Y; Kurokawa K
Biochim Biophys Acta; 1996 Nov; 1304(2):161-9. PubMed ID: 8954139
[TBL] [Abstract][Full Text] [Related]
48. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation.
Rodríguez-Liñares B; Watson SP
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):93-8. PubMed ID: 8645238
[TBL] [Abstract][Full Text] [Related]
49. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
51. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets.
Murthy M; Rao GH; Robinson P; Reddy S
Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):31-9. PubMed ID: 7675820
[TBL] [Abstract][Full Text] [Related]
52. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
[TBL] [Abstract][Full Text] [Related]
53. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
54. Comparison of maitotoxin with thromboxane A2 in rabbit platelet activation.
Nakahata N; Ohkubo S; Ito E; Nakano M; Terao K; Ohizumi Y
Toxicon; 1999 Oct; 37(10):1375-89. PubMed ID: 10414863
[TBL] [Abstract][Full Text] [Related]
55. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
56. Alterations by a thromboxane A2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes.
Hoffmann P; Heinroth-Hoffmann I; Toraason M
J Pharmacol Exp Ther; 1993 Jan; 264(1):336-44. PubMed ID: 8423535
[TBL] [Abstract][Full Text] [Related]
57. Aggregation of human and canine platelets: modulation by purine nucleotides.
Soslau G; Arabe L; Parker J; Pelleg A
Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650
[TBL] [Abstract][Full Text] [Related]
58. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
Yamada Y; Furui H; Furumichi T; Suzuki T; Yamauchi K; Yokota M; Hayashi H; Saito H
Jpn Heart J; 1990 Mar; 31(2):201-15. PubMed ID: 2113109
[TBL] [Abstract][Full Text] [Related]
60. Effects of thromboxane A2 on lymphocyte proliferation.
Ceuppens JL; Vertessen S; Deckmyn H; Vermylen J
Cell Immunol; 1985 Feb; 90(2):458-63. PubMed ID: 3155656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
